ATE453634T1 - Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen - Google Patents

Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen

Info

Publication number
ATE453634T1
ATE453634T1 AT06813938T AT06813938T ATE453634T1 AT E453634 T1 ATE453634 T1 AT E453634T1 AT 06813938 T AT06813938 T AT 06813938T AT 06813938 T AT06813938 T AT 06813938T AT E453634 T1 ATE453634 T1 AT E453634T1
Authority
AT
Austria
Prior art keywords
thiophenes
preparing benzimidazole
regioselective process
preparing
benzimidazole
Prior art date
Application number
AT06813938T
Other languages
English (en)
Inventor
Keith Hornberger
Mui Cheung
Mark Pobanz
Kyle Emmitte
Kevin Kuntz
Jennifer Badiang
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE453634T1 publication Critical patent/ATE453634T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D333/40Thiophene-2-carboxylic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AT06813938T 2005-09-06 2006-08-28 Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen ATE453634T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71430105P 2005-09-06 2005-09-06
PCT/US2006/033793 WO2007030366A1 (en) 2005-09-06 2006-08-28 Regioselective process for preparing benzimidazole thiophenes

Publications (1)

Publication Number Publication Date
ATE453634T1 true ATE453634T1 (de) 2010-01-15

Family

ID=37605702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06813938T ATE453634T1 (de) 2005-09-06 2006-08-28 Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen

Country Status (18)

Country Link
US (1) US20080249301A1 (de)
EP (1) EP1924572B1 (de)
JP (1) JP2009507022A (de)
KR (1) KR20080045266A (de)
CN (1) CN101304986A (de)
AT (1) ATE453634T1 (de)
AU (1) AU2006287771A1 (de)
BR (1) BRPI0615705A2 (de)
CA (1) CA2621073A1 (de)
DE (1) DE602006011482D1 (de)
EA (1) EA200800549A1 (de)
ES (1) ES2338590T3 (de)
IL (1) IL189769A0 (de)
MA (1) MA29781B1 (de)
MX (1) MX2008003172A (de)
NO (1) NO20081101L (de)
WO (1) WO2007030366A1 (de)
ZA (1) ZA200801950B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA014111B1 (ru) * 2005-09-06 2010-10-29 Смитклайн Бичем Корпорейшн Бензимидазолтиофеновые соединения в качестве ингибиторов polo-подобных киназ (plk)
US20080214563A1 (en) * 2005-09-06 2008-09-04 Mui Cheung Benzimidazole Thiophene Compounds As Plk Modulators
EP2474546A1 (de) * 2006-01-23 2012-07-11 Vertex Pharmaceuticals Inc. Thiophencarboxamide als Proteinkinaseinhibitoren
WO2007120760A2 (en) 2006-04-13 2007-10-25 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007139816A2 (en) 2006-05-23 2007-12-06 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007139795A1 (en) 2006-05-23 2007-12-06 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
US7615643B2 (en) 2006-06-02 2009-11-10 Smithkline Beecham Corporation Benzimidazole thiophene compounds
EP2170871A2 (de) * 2007-06-26 2010-04-07 GlaxoSmithKline LLC Verfahren zur herstellung von benzimidazolthiophenen
EP2100894A1 (de) 2008-03-12 2009-09-16 4Sc Ag Pyridopyrimidinone verwendbar als Plk1 (polo-like kinase) Hemmen
EP2558437B1 (de) * 2010-04-12 2015-08-05 Supernus Pharmaceuticals, Inc. Verfahren zur herstellung von viloxazinsalzen und neue polymorphe daraus
US20130315895A1 (en) 2010-07-01 2013-11-28 Takeda Pharmaceutical Company Limited COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
US8754114B2 (en) * 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
EP2565186A1 (de) 2011-09-02 2013-03-06 Hybrigenics S.A. Spezifische und reversible Inhibitoren von ubiquitinspezifischer Protease 7
RU2014144951A (ru) 2012-04-10 2016-06-10 Сумитомо Дайниппон Фарма Ко., Лтд. Новое 1-замещенное производное индазола
RS58514B1 (sr) 2012-06-13 2019-04-30 Incyte Holdings Corp Supstituisana triciklična jedinjenja kao inhibitori fgfr
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
PH12015502383B1 (en) 2013-04-19 2023-02-03 Incyte Holdings Corp Bicyclic heterocycles as fgfr inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
TWI712601B (zh) 2015-02-20 2020-12-11 美商英塞特公司 作為fgfr抑制劑之雙環雜環
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
WO2019126731A1 (en) 2017-12-22 2019-06-27 Petra Pharma Corporation Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
HRP20241288T1 (hr) 2018-05-04 2024-12-06 Incyte Corporation Čvrsti oblici fgfr inhibitora i postupci za njihovu proizvodnju
AU2019262579B2 (en) 2018-05-04 2024-09-12 Incyte Corporation Salts of an FGFR inhibitor
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
CN109988098A (zh) * 2019-05-23 2019-07-09 常州工程职业技术学院 一种(r)-n-叔丁氧羰基-3-羟甲基哌啶的合成方法
TW202112767A (zh) 2019-06-17 2021-04-01 美商佩特拉製藥公司 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
CA3157361A1 (en) 2019-10-14 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
CA3163875A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
JP7832891B2 (ja) 2019-12-04 2026-03-18 インサイト・コーポレイション Fgfr阻害剤の誘導体
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2022221170A1 (en) 2021-04-12 2022-10-20 Incyte Corporation Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
US11939331B2 (en) 2021-06-09 2024-03-26 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors
CA3220155A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990146A (en) * 1997-08-20 1999-11-23 Warner-Lambert Company Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
US6162804A (en) * 1997-09-26 2000-12-19 Merck & Co., Inc. Tyrosine kinase inhibitors
GB0005642D0 (en) * 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds
CA2465328C (en) * 2001-11-01 2011-06-14 Michael Francis Gross Piperidines
BR0313160A (pt) * 2002-08-08 2005-07-12 Smithkline Beecham Corp Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
EP1558599A4 (de) * 2002-10-30 2007-06-27 Merck & Co Inc Heteroarylpiperidinmodulatoren derchemokinrezeptoraktivitüt
EP1685128A1 (de) * 2003-10-16 2006-08-02 Smithkline Beecham Corporation Verfahren zur herstellung von benzimidazolthiophenen

Also Published As

Publication number Publication date
AU2006287771A1 (en) 2007-03-15
MA29781B1 (fr) 2008-09-01
EP1924572A1 (de) 2008-05-28
IL189769A0 (en) 2008-08-07
DE602006011482D1 (de) 2010-02-11
MX2008003172A (es) 2008-03-18
JP2009507022A (ja) 2009-02-19
EP1924572B1 (de) 2009-12-30
ES2338590T3 (es) 2010-05-10
EA200800549A1 (ru) 2008-08-29
BRPI0615705A2 (pt) 2016-08-23
KR20080045266A (ko) 2008-05-22
NO20081101L (no) 2008-04-04
WO2007030366A1 (en) 2007-03-15
CN101304986A (zh) 2008-11-12
CA2621073A1 (en) 2007-03-15
US20080249301A1 (en) 2008-10-09
ZA200801950B (en) 2009-09-30

Similar Documents

Publication Publication Date Title
ATE453634T1 (de) Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen
EP2038375A4 (de) Verfahren zur herstellung von grundölen
UY33981A (es) ?método para preparar compuestos macrocíclicos inhibidores de serina proteasas de hepatitis c?.
CY1110010T1 (el) Πυριδιναμινοσουλφονυλ υποκατεστημενα βενζαμιδια ως αναστολεις κυτοχρωματος ρ450 3α4 (cyp3a4)
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
DE502006001614D1 (de) Verfahren zur herstellung von 1-alkyl-3-phenyluracilen
DE602007013512D1 (de) Verfahren zur kontinuierlichen Herstellung von Bauteilen
ATE522518T1 (de) Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
SI3336073T1 (sl) Postopek za proizvodnjo fluoriranih organskih spojin
EA200900945A1 (ru) Новый способ синтеза агомелатина
DE602005015174D1 (de) Verfahren zur herstellung von montelukast-natrium
CY1118173T1 (el) 5-[(3,3,3-τριφθορο-2-υδροξυ-1-αρυλπροπυλ)αμινο]-1h-κινολιν-2-ονες, μια διεργασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδων παραγοντων
EA200900946A1 (ru) Новый способ синтеза агомелатина
DE602006017743D1 (de) Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamiden
CY1112520T1 (el) Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
DE502005004141D1 (de) Verfahren zur kompensation von thermischen verlagerungen
DE602007011324D1 (de) Verfahren zur herstellung von 2-substituierten 5-(1-alkylthio)alkylpyridinen
ATE519722T1 (de) Verfahren zur palladiumkatalysierten kopplung von terminalalkynen mit aryltosylaten
DE112009000076A5 (de) Verfahren zur Herstellung von Urethanen
DE502007003531D1 (de) Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten
DE502007000339D1 (de) Verfahren zur Herstellung von Urethangruppen aufweisenden Organosiliciumverbindungen
EA200900943A1 (ru) Новый способ синтеза агомелатина
DE502007000718D1 (de) Verfahren zur Herstellung von Carbidkeramik-Bauteilen
DE602004014264D1 (de) Verfahren zur herstellung von olanzapin
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties